Comunicati.net - Comunicati pubblicati - Comuni Comunicati.net - Comunicati pubblicati - Comuni Fri, 16 Apr 2021 15:39:41 +0200 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://comunicati.net/comunicati/istituzioni/comuni/1 The Traditional Chinese Medicine Market To Grow Seamlessly Between 2020 to 2030 Thu, 15 Apr 2021 15:11:20 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702867.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702867.html persistencemarketresearch persistencemarketresearch

Traditional Chinese medicine is one of the oldest systems of health and wellness that has been used in China for thousands of years. Other medicines mainly focus on treating a disease. But traditional Chinese medicines aim to increase immune power and look at the entire well-being. The most common type of traditional Chinese medicines includes herbal products, acupuncture, and Tai Chi, among others.

According to a latest report published by PMR, the global traditional Chinese medicine market is expected to witness a CAGR of more than 5% over the forecast period (2020–2030).

Strategizing The Moves For The Next Decade? See Through Sample Of Traditional Chinese Medicine Market Report! https://www.persistencemarketresearch.co/samples/16219

Companies covered in Traditional Chinese Medicine Market Report

  • Tongrentang
  • Zhongxin Pharmaceuticals
  • Tianjin Tasly Group
  • Yuannan Baiyao
  • Solstice Medicine Company, Inc.
  • Shanghai Sundise Traditional Chinese Medicine Co., Ltd
  • China Chinese Medicine Holding Co., Ltd.
  • Hunan goldliloo pharmaceutical Co., Ltd
  • Wanbang Pharma Group Corp.
  • Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
  • Pfizer Inc.
  • Eli Lilly and Company
  • Novartis AG
  • GlaxoSmithKline PLC
  • Mallinckrodt Pharmaceuticals
  • Hisamitsu Pharmaceutical Co., Inc.

Starting With The New Decade On A Diligent Note In The Traditional Chinese Medicine Market? https://www.persistencemarketresearch.co/methodology/16219

 Key Takeaways from Traditional Chinese Medicine Market Study   

  • Non-traditional Chinese medicines is the leading segment by product in the global traditional Chinese medicine market. The Autism Spectrum disorder (ASD) segment has been gaining more traction in recent years, and is expected to expand at a rate of 6.7% during the forecast period.
  • North America is the leading region in the traditional Chinese medicine market, followed by Europe.
  • East and South Asia, including China, South Korea, Japan, India, and ASEAN countries, is the fastest-growing region in the traditional Chinese medicine market, due improving medical infrastructure.
  • Tong Ren Tang, Pfizer, and Novartis AG are amongst the leading players in the global traditional Chinese medicine market. These companies invest most of their revenue in R&D, and focus on strengthening their distribution channels to maintain a leading position in the traditional Chinese medicine market space.
  • 100+ health systems are partnering with retail chains, providing physician oversights and increased patient traffic to retail clinics, and extending health system networks to new patient populations.
  • The COVID-19 pandemic is a cause for concern, which has deprioritized non-essential medical treatments. This will hurt the growth of the global traditional Chinese medicine market in the short term.

How About Obtaining Insights About The Region To Enter Concerning The Traditional Chinese Medicine Market? Press The “Purchase Now” Button To Have Our Traditional Chinese Medicine Market Report! https://www.persistencemarketresearch.com/checkout/16219

“Increasing incidence of ADHD to boost growth of global traditional Chinese medicine market,” says a PMR analyst.

Rising prevalence of ADHD is a major factor contributing to revenue growth of the traditional Chinese medicine market across the globe. The exact cause of ADHD is still unclear, although genetic influence is observed in most cases.

As per data released by the Centers for Disease Control and Prevention (CDC), approximately 6.1 million (9.4%) – 388,000 children aged 2–5 years, million children aged 6–11 years, and 3 million children aged 12–17 years – were diagnosed with ADHD in the U.S. In Spain, pooled prevalence of ADHD in a population of 361,580 representing children and adolescents was estimated at 6.8% from the last decade.

Prevalence of ADHD is rising at an alarming rate, which is expected to fuel revenue growth of ADHD therapeutics such traditional Chinese medicines, as there is no specific treatment for this disorder.

Product Innovation – Key Strategy of Traditional Chinese Medicine Market Players

Major players in the global traditional Chinese medicine market are introducing innovative products to retain their market share. A patented technology called osmotic controlled release oral delivery system (OROS) is used in Concerta, manufactured by Johnson & Johnson. It releases an initial dose of methylphenidate within the first two hours of ingestion, and when the pill passes through the stomach and gastrointestinal track, water is absorbed, resulting in internal pressure, which releases small amounts of medication as the pill passes through gut. This technology was implemented to maintain consistency of improvement in cognitive performance throughout the day.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Facial Mask Market To Witness A Growth-Wise Disruption Between 2020 to 2030 Thu, 15 Apr 2021 15:10:57 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702866.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702866.html persistencemarketresearch persistencemarketresearch Sedentary lifestyle, rising geriatric population, and increasing number of people suffering from chronic diseases such as cancer, pulmonary disorders, and cardio vascular disorders have led to increase in number of surgeries. Use of facial masks during surgeries and rapid adoption of oxygen therapy is set to drive the growth of the facial mask market.

Substantial change in the burden of respiratory diseases such as chronic obstructive pulmonary diseases (COPD) and asthma has been observed, which will widen opportunities for manufacturers in the facial mask market. Medical mask market growth has been massive during the COVID-19 pandemic, as personal protection equipment (PPE) is the need of an hour.

The COVID-19 pandemic has had a positive impact on the growth of the facial mask market. Demand for N95 respiratory and surgical masks has been surging throughout the pandemic.

Want Insights To Facial Mask Market? Ask For Sample! https://www.persistencemarketresearch.co/samples/32028

Companies covered in Facial Mask Market Report

  • 3M Co
  • Honeywell International Inc
  • Dragerwerk AG & Co KgaA
  • Fisher & Paykel Healthcare Corporation Ltd.
  • Air Liquide Medical Systems
  • Cardinal Health
  • Koninklijke Philips NV
  • CAntel Medical Corp
  • Teleflex Inc.
  • ResMEd
  • Well Lead Medical Co Ltd
  • Ambu AS
  • Vincent Medical
  • Flexicare Medical Ltd
  • SunMed LLC
  • Besmed

Planning To Conclude Your Strategy On A Decisive Note In The Facial Mask Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.co/methodology/32028

The global facial mask market is slated to expand at a CAGR of close to 5%, and cross a valuation of US$ 7 Bn by 2030-end.

Key Takeaways from Facial Mask Market Study

  • Based on product, anesthesia masks is the most profitable segment, and holds around half the market value share. This is due to increasing number of surgeries that require anesthesia administration.
  • In terms of usage, reusable facial masks is the leading segment, and is expected to grow 1.6X over the forecast period. Reusable masks are cost-effective and pose lower environmental burden.
  • During the COVID19 pandemic, many manufactures from Europe realized the potential of revenue growth and took the opportunity to launch various medical masks and respirators.
  • Among the various distribution channels, hospitals and retail pharmacies lead the facial mask market. Hospitals are major consumers of facial masks due to high number of surgical procedures.

How About Knowing The Product/Technology Driving The Facial Mask Market Before Investing Therein? Click The “Purchase Now” Button Of Our Facial Mask Market Report! https://www.persistencemarketresearch.com/checkout/32028

“Rising prevalence of chronic diseases, especially respiratory disorders, growing burden of surgeries, and increasing awareness regarding personal and patient safety are factors expected to boost the growth of the global facial mask market. The COVID-19 pandemic has boosted market growth due to the unstoppable demand for facial masks. Due to this impact, year-on-year growth has increased to 3.9% in 2020 from 3.7% in 2019,” says a PMR analyst.

Growing Trends in Facial Mask Market

Rising awareness about effective respiratory protection and management in developed countries such as the U.S. and U.K. are seen with promotional advertisements and training programs about the usage of facial masks. Such awareness programs will help in educating people and will ultimately surge the growth of the facial mask market.

Growing preference for non-invasive ventilation masks and circuits for long-term oxygen therapy patients has also been seen in recent times. This has reduced hospital and ICU stays. Growing popularity of these masks will propel facial mask market growth.

Expansion of Manufacturing Capabilities and New Product Launches - Key Strategies by Market Players

  • Key players in the facial mask market are expanding their manufacturing capabilities to meet the unmet demand for facial masks. The pandemic scenario has encouraged many manufacturers to focus on in-house production, and thus expand their market presence by reaching out to a larger population. For instance, Honeywell expanded its face mask production In Europe with a new manufacturing line in the United Kingdom, in May 2020. In July 2020, Drager expanded its capability for respiratory masks and opened a production facility in the U.K.
  • With e-Commerce becoming a convenient sales platform for facial mask manufactures, sales will increase further in the future.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the facial mask market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, based on product (medical masks [anesthesia masks, non-invasive ventilation masks, oxygen masks, and aerosol masks], respirators [single strap masks, filter dust masks, half-face masks, full-face masks, and PAPRs]) usage (reusable and disposable masks), and distribution channel (institutional sales [hospitals, ambulatory surgical centers, office-based clinics, skilled nursing facilities, diagnostic laboratories, and academic and research institutes] and retail sales [retail pharmacies, drug stores, mail over pharmacies, retail stores, and online sales]), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Antibody Testing Market To Ruffle Healthy Feathers Between 2020 to 2030 Thu, 15 Apr 2021 15:10:35 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702865.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702865.html persistencemarketresearch persistencemarketresearch Rapid diagnosis is crucial, and any delay can not only worsen a patient’s condition but can also result in unregulated spread of infection, as seen with the COVID-19 pandemic.

The antibody testing market includes an extensive portfolio of products catering to many indications, such as cardiovascular disorders, autoimmune diseases, and bacterial and viral infectious diseases. Manufacturers not only offer test kits for various indications, but also provide choices for various types of antibody test kits, such as serological test kits, immunoglobulin assay kits, and lateral flow assay kits.

How About Looking Through The Sample Of Antibody Testing Market Report? https://www.persistencemarketresearch.co/samples/31930

Companies covered in Antibody Testing Market Report

  • Thermo Fisher Scientific.
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Beckton, Dickinson and Company
  • F. Hoffmann-La Roche
  • Agilent Technologies
  • DiaSorin
  • Zeus Scientific
  • Abcam
  • Trinity Biotech
  • Werfen (Biokit)
  • Promega
  • BioLegend
  • Meridian Bioscience
  • Bio-Techne (R&D Systems)

How About Step-By-Step Insights To Antibody Testing Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.co/methodology/31930

As per Persistence Market Research, the global antibody testing market will experience a healthy CAGR of 8% during the forecast period of 2020-2030.

Key Takeaways from Antibody Testing Market Study    

  • The serological test kit product segment is expected to be the most lucrative segment in the global antibody testing market by the end of 2030.
  • By indication, the infectious diseases segment is expected to grow 2.6 times from the year 2020 to 2030.
  • In terms of end user, the diagnostic laboratories segment is expected to hold 2/5 market share of the entire global market value in the antibody testing market.
  • Due to the COVID-19 outbreak, the infection segment increased from 7% in year-on-year growth in 2018 to 2019 to nearly 12% in 2020.
  • Countries such as China, India, and Brazil have the potential to drive the future growth of the antibody testing market, owing to the growing burden of infectious and chronic diseases such as diabetes across these regions.

Want To Keep A Tab On The Latest Findings In The Antibody Testing Market? Purchase Our Antibody Testing Market Report Now! https://www.persistencemarketresearch.com/checkout/31930

“Growing diseases outbreak due to changing planetary dynamics and rising patient preference for rapid diagnosis will spur the growth of the antibody testing market over the coming years,” says a PMR analyst.

Infectious Disease Epidemic Potential to Boost Market Growth

In 2014, the Ebola outbreak in Western Africa was a cause of concern for healthcare scholars, worldwide. This was followed by the Zika outbreak in 2016, and then the present COVID-19 crisis. Growing prevalence of infectious diseases and their potential to cause an outbreak or epidemic is the major reason that, in the antibody testing market, the infectious diseases segment has the highest growth potential over the forecast period. Although non-communicable diseases are the topmost cause of mortality in developed countries, infectious diseases continue to remain a key concern, as they have the potential to turn into major outbreaks, as seen with the COVID-19 pandemic.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the antibody testing market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of product (serological test kits [serological assay test kits, serological rapid assay kits], immunoglobulin kits [immunoglobulin assay test kits, immunoglobulin rapid assay kits], lateral flow assay kits [lateral flow assay test kits, lateral flow rapid assay kits], chemicals and reagents, and consumables), indication (pregnancy, cardiovascular disease, autoimmune disease, infectious disease, oncology, endocrine disease, diabetes, and others), and end user (hospitals, academic and research institutes, diagnostic laboratories, biopharmaceutical companies, and homecare settings), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Urothelial Carcinoma Diagnostics Market To Resonate With Growth Between 2020 to 2030 Thu, 15 Apr 2021 15:10:13 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702864.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702864.html persistencemarketresearch persistencemarketresearch According to World Health Organization (WHO) estimates, every year, 3.8 Mn new cases of urothelial carcinoma occur around the world, with the recurrence rate being nearly 30-50%. However, early detection by use of modern diagnostics enables quick medical decision-making and consequent treatment for urothelial carcinoma. Accuracy in urothelial carcinoma diagnostics plays a significant role in the reduction of treatment costs.

Moreover, increased demand for treatment of urothelial carcinoma is a key driver for increasing revenue inflow from diagnostic tests and procedures. However, development of effective urothelial carcinoma screening methods will play a significant role in the early detection and subsequent reduction in mortality rates. Furthermore, technological advancements in diagnostic methods such as the adoption of diagnostic imaging procedures, rapid molecular diagnostic kits, and use of biomarker testing in urothelial carcinoma screening programs are some other factors that will aid the growth of the urothelial carcinoma diagnostics market.

How About Looking Through The Sample Of Urothelial Carcinoma Diagnostics Market Report? https://www.persistencemarketresearch.co/samples/14128

Companies covered in Urothelial Carcinoma Diagnostics Market Report

  • GE Healthcare
  • Roche Holding
  • Illumina
  • IDL Biotech
  • Agilent Technologies
  • Olympus Corporation
  • Philips Healthcare
  • Abbott Molecular
  • Bio-Rad Laboratories, Inc
  • Thermo Fisher Scientific, Inc.( Qiagen N.V.)
  • Danaher Corporation (Cepheid)

How About Step-By-Step Insights To Urothelial Carcinoma Diagnostics Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.co/methodology/14128

According to the latest report published by PMR, the global urothelial carcinoma diagnostics market was valued at US$ 1 Bn in 2020, and is expected to progress at a CAGR of over 11% during the forecast period (20202030).

 Key Takeaways from Urothelial Carcinoma Diagnostics Market Study         

  • The reagent and kits segment, under product type, is expected to contribute more than 70% of revenue share in the urothelial carcinoma diagnostics market.
  • By test type, molecular diagnostic tests accounted for the highest revenue in 2019. Rapid and sensitive detection is anticipated to drive demand for urothelial carcinoma diagnostics.
  • Based on end user, the hospitals segment accounts for a major revenue share in the urothelial carcinoma diagnostics market.
  • Leading players launching rapid diagnostic products with advances technology are expected to dominate the urothelial carcinoma diagnostics market space.
  • Governments of various countries are organizing cancer screening programs and are spreading awareness, which is creating significant demand for urothelial carcinoma diagnostics.
  • The COVID-19 outbreak has resulted in manufacturing disruptions and also decreased demand, which is projected to impede market growth in the near term.

Want To Keep A Tab On The Latest Findings In The Urothelial Carcinoma Diagnostics Market? Purchase Our Urothelial Carcinoma Diagnostics Market Report Now! https://www.persistencemarketresearch.com/checkout/14128

“Rise in prevalence of urothelial carcinoma and demand for early detection for preventive treatments will boost the global urothelial carcinoma diagnostics market,” says a PMR analyst.

Acquisitions and Partnerships - Key Strategies amongst Market Players

Key players in the urothelial carcinoma diagnostics market are looking forward to strengthening their product portfolios through the launch of new products. For instance, in 2017, Roche received FDA approval for the complementary PD-L1 (SP263) biomarker test in urothelial carcinoma. In August2018, Agilent Technologies, Inc announced that the US Food and Drug Administration approved its Dako PD-L1 IHC 22C3 pharmDx assay for expanded use as a companion diagnostic test for Merck's anti-PD1 immunotherapy Keytruda (pembrolizumab) for urothelial carcinoma.

Various players in the urothelial carcinoma diagnostics market are focusing on growth strategies such as acquisitions and partnerships. For example, in 2020, Thermo Fisher Scientific signed an agreement with Janssen to co-develop companion diagnostics for cancer.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the urothelial carcinoma diagnostics market in its latest study, presenting historical demand assessment of 20152019 and projections for 20202020, on the basis of product type (reagents and kits, instruments), test type (urinalysis test, molecular diagnostic test, biomarker test, imaging test, cytoscopy, ureteroscopy), and end user (hospitals, diagnostic laboratories, research and academic institutes, clinical research organizations), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Pharmaceutical Excipients For Taste Masking Market To Move To “Growth Absorption” Spectrum Between 2020 to 2030 Thu, 15 Apr 2021 15:09:51 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702863.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702863.html persistencemarketresearch persistencemarketresearch Adoption of pharmaceutical excipients for taste masking techniques for achieving patient compliance with the drugs, and its acceptability especially amongst the geriatric and pediatric population, are set to drive market growth. Oral administration of medicines with an unpleasant taste is a major problem faced by patient groups.

Taste masking technique is a key success determinant for oral dosage forms such as tablets. As the oral route is thought to be the most convenient for drug administration, the growth of the pharmaceutical excipients for taste masking market is expected to see an upswing over the coming years. Also, increasing geriatric population and rising incidence of chronic diseases such as diabetes, cancer, and cardiovascular diseases will drive the growth of the pharmaceutical excipients for taste masking market, globally, at a CAGR of over 5% through 2030.

Strategizing The Moves For The Next Decade? See Through Sample Of Pharmaceutical Excipients For Taste Masking Market Report! https://www.persistencemarketresearch.co/samples/14743

Companies covered in Pharmaceutical Excipients For Taste Masking Market Report

  • Adare Pharmaceutical Inc.
  • Asahi Kasei Corporation
  • Gattefossé
  • SPI Pharma, Inc
  • Roquette Frères
  • GPT Pharmaceuticals Pvt. Ltd
  • DuPont de Nemours, Inc.
  • Rochem International, Inc
  • Dow Pharma Solutions

Starting With The New Decade On A Diligent Note In The Pharmaceutical Excipients For Taste Masking Market? https://www.persistencemarketresearch.co/methodology/14743

Key Takeaways from Pharmaceutical Excipients for Taste Masking Market Study

  • Based on pharmaceutical excipient masking agents, artificial masking excipients is the most profitable segment, with a market value share of around 34%, due to the higher adoption of the artificial agents in taste masking processes.
  • Growing aging population and adoption of medicines for the pediatric population around the world will increase the demand for pharmaceutical excipients for taste masking products over the forecast period.
  • In terms of technique, coating is the leading segment, owing to its efficiency in masking the taste of APIs in final finished products.
  • Europe is the most lucrative market in the global pharmaceutical excipients for taste masking market, and holds around 1/3 of the market share, owing to higher cost API processing in the region.
  • As end users, pharmaceutical companies lead the market due to high in-house production of drugs by major pharmaceutical companies.
  • The COVID-19 pandemic has led to lockdowns and restrictions, which has adversely affected the production of pharmaceutical excipients for taste masking agents.

“Rising demand for medicines to treat chronic disease conditions, and increasing demand for oral and patient compatible medicines such as those with pleasant taste, are the main factors expected to contribute in propelling the growth of the global pharmaceutical excipients for taste masking market over the coming years,” says a PMR analyst.

How About Obtaining Insights About The Region To Enter Concerning The Pharmaceutical Excipients For Taste Masking Market? Press The “Purchase Now” Button To Have Our Pharmaceutical Excipients For Taste Masking Market Report! https://www.persistencemarketresearch.com/checkout/14743

Growing Trends in Drug Formulation

Oral drugs are popular as they easy ingestible and absorbable. As such, good taste of the medicine is a necessary feature for patient compliance with the medicines. Patient compliance with oral medicines will boost the growth of the pharmaceutical excipients for taste masking market. The market is expected to exhibit significant growth in terms of CAGR during the forecast period (2020-2030).

Key Strategy amongst Market Players

Key players in the pharmaceutical excipients for taste masking market are focused on strengthening their market presence through a variety of taste masking technologies and with the development of new platforms. These include stimuli responsive systems for drug delivery by including pH-sensitive and ion-sensitive polymers to mask the bitter taste of drugs. For instance, Acetaminophen is masked with Shellac, which is a natural polymer meant to mask bitter taste.

What else is in the report?

Persistence Market Research offers a unique perspective and actionable insights on the pharmaceutical excipients for taste masking market in its latest study, presenting historical demand assessment of 20152019 and projections for 20202030, based on type (natural, artificial, nutritive, non- nutritive, polyols, and others), technique (hot melt extrusion, microencapsulation, coating, organoleptic methods, and others), usage (solid dosage forms-tablets, granules, capsules, and liquid dosage forms), and end use (pharmaceuticals, nutraceuticals, and contract manufacturing organizations), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Surgical Helmet System Market To Surpass Covid-19 Cringe From 2020 to 2030 Onwards Thu, 15 Apr 2021 15:09:29 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702862.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702862.html persistencemarketresearch persistencemarketresearch Increasing number of orthopaedic surgeries such as total joint replacement and their rising acceptance is creating opportunities for the surgical helmet systems market. These systems are required for the protection of surgeons from hospital- and patient-acquired infections. Moreover, increasing awareness regarding healthcare workers’ safety and comfort needed by surgeons during operative procedures have led to the growth of the market. Orthopaedic impairments are very common in the Americans, and the number of orthopaedic surgeries is expected to reach 6.6 million in 2020 from 5.5 million in 2010. The aspect of surgical helmet systems to protect healthcare professionals against infectious blood splashes and potential aerosols generated by orthopaedic power tools has escalated the growth of the surgical helmet systems market.

The global surgical helmet systems market is projected to expand at a CAGR of 4% through 2030, to reach a value of US$ 80 Mn in 2030.

Get Going With Sample Of Surgical Helmet System Market Report! https://www.persistencemarketresearch.co/samples/27532

Companies covered in Surgical Helmet System Market Report

  • Zimmer Biomet.
  • Stryker
  • Ecolab
  • THI Total Healthcare Innovation GmbH
  • Kaiser Technology Co., Ltd.
  • Beijing Zhongke Shengkang Technology Co., Ltd

How About Re-Inventing The Methodical Wheel In The Surgical Helmet System Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.co/methodology/27532

 Key Takeaways from Surgical Helmet Systems Market Study

  • The surgical helmet systems market is expected to grow rapidly, owing to the increased number of musculoskeletal operations, worldwide.
  • The ‘with LED’ segment is expected to be the most preferred choice under product type in the surgical helmet systems market.
  • Hospitals are the most common end users of surgical helmet systems.
  • North America dominates the surgical helmet systems market in terms of total market share, accounting for around 1/3 market share amongst all other regions.
  • Key players in the surgical helmet systems market are focusing on innovation and product customization through rigorous research & development, to maintain and strengthen their market presence, both, regionally and internationally.
  • The COVID-19 pandemic has not has such a big impact on the surgical helmet systems market, which only supply chain disruptions causing some strain.

Keeping A Tab On Key Players In The Surgical Helmet System Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Surgical Helmet System Market Report! https://www.persistencemarketresearch.com/checkout/27532

“Rise in the number of orthopaedic surgeries and increasing safety concerns amongst healthcare professionals across the world are major factors responsible for the growth of the surgical helmet systems market,” says a PMR analyst.

Product Innovation & Customized Design Modifications are Key Strategies amongst Market Players

  • Key players in the surgical helmet systems market are focusing on strengthening their market presence through new design modifications and technology advancements. For instance, THI’s patented a surgical helmet system called ViVi, which is modified to have two fan systems to filter out waste air and ensure proper ventilation during surgeries.
  • Surgical helmet systems product modifications are based on factors such as ergonomic factors, durability of the product, making it disposable or reusable, and use of lightweight material for manufacturing products.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the surgical helmet systems market in its latest study, presenting historical demand assessment of 20152019 and projections for 20202030, on the basis of product type (without LED and with LED) and end user (hospitals, ambulatory surgical centres, and academic and research institutes), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Single-Domain Antibody Platforms Market To Get Streamlined On A Healthy Front Between 2020 to 2030 Wed, 14 Apr 2021 15:27:46 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702535.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702535.html persistencemarketresearch persistencemarketresearch

Monoclonal antibodies are highly efficient as therapeutics against viral infections, immune diseases, and cancer. However, they are large in size and unable to access some epitopes, besides the production cost being high. Hence, single-domain antibodies (sdAbs) is an alternative for monoclonal due to larger number of accessible epitopes, smaller size, relatively low production costs, and potent inhibitors against immune and viral diseases. Currently, single-domain antibodies are being developed against a number of viruses, including influenza viruses, HIV, hepatitis C virus (HCV), enteric viruses, and respiratory syncytial virus (RSV).

Technological advancements in single-domain antibody platforms such as production of bispecific and multi-specific antibodies to target particular antigens during therapeutic developments are some other factors that will boost the growth of the single-domain antibody platforms market.

Planning Forward? Access Sample Of Single-Domain Antibody Platforms Market Report! https://www.persistencemarketresearch.co/samples/28351

Companies covered in Single Domain Antibody Platforms Market Report

  • Creative BioLabs A
  • Synbio Technologies
  • ProSci Incorporated
  • BioCat GmbH
  • Antibody Design Labs
  • GenScript
  • Oak BioSciences, Inc.
  • Rockland Immunochemicals, Inc
  • Hybrigenics Services
  • NeoClone Biotechnology International LLC
  • Kaneka Eurogentec S.A
  • ProteoGenix

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Single-Domain Antibody Platforms Market? https://www.persistencemarketresearch.co/methodology/28351

According to a latest report published by PMR, the global single-domain antibody platforms market is projected to be valued at US$ 22 Mn in 2020, and is expected to witness an impressive CAGR of around 10% during the forecast period (2020 – 2030).

 Key Takeaways from Single-Domain Antibody Platforms Market Study     

  • The bispecific single-domain antibody segment under platform type is expected to contribute more than 30% of revenue share in the single-domain antibody platforms market.
  • By application, therapeutic development accounted for the highest market share in 2019. Single-domain antibodies are highly effective in immune therapy, and antiviral therapy is anticipated to drive demand for single-domain antibody platforms.
  • Developing countries such as India, China, and South Africa are projected to register positive growth over the coming years, due to increase in drug development activities in these regions.
  • Leading players are focused on improving their service and established collaborations with research institutes and provide customized products.
  • The COVID-19 outbreak has created a positive impact on the single-domain antibody platforms market, with increased demand for antibodies in the treatment against COVID-19.

“Rise in prevalence of infectious disease and demand for immunotherapy for preventive treatments will boost the global single-domain antibody platforms market,” says a PMR analyst.

Planning To Introduce An Offbeat Product/Technology In The Single-Domain Antibody Platforms Market? Go To “Purchase Now” To Have Our Single-Domain Antibody Platforms Market Report! https://www.persistencemarketresearch.com/checkout/28351

Collaborations & Acquisitions – Key Strategies amongst Market Players

Leading players in the single-domain antibody platforms market are strengthening their product portfolios by launching new products.

  • For instance, in July 2020, Creative Biolabs developed over 400 types of therapeutic antibodies that can be applied to the study on COVID-19 drugs.
  • ProSci Incorporated announced the release of multiple single-domain antibodies against the human programmed death ligand 1 (PD-L1).
  • In May, 2016, Antibody Design Labs offered a complete line of services for single-domain antibody development, including single-domain antibody phage libraries, immunization, and large-scale production of recombinant single-domain antibodies

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the single-domain antibody platforms market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of platform type (multi-specific single-domain antibody, bispecific single-domain antibody, multivalent single-domain antibody, and mono-specific single-domain antibody), animal source (camelids and sharks), application (diagnostic laboratories, therapeutic development, and research & development activities) and end user (diagnostic laboratories, clinical laboratories, academic and research institutes, and pharmaceutical and biotechnology companies), across seven key regions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Hematology Analyzers Market To Grow Seamlessly Between 2024 Wed, 14 Apr 2021 15:27:23 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702533.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702533.html persistencemarketresearch persistencemarketresearch

Automation is one of the key technology advancements in the hematology analyzers market. Automatic and semi-automatic hematology systems are being rapidly adopted across the world, along with rising prevalence of hematological disorders such as leukemia, hemophilia, and anemia. According to the World Federation of Hemophilia, prevalence of hemophilia among male patients was found to be around 17 per 100,000 males, globally, in 2019.

Additionally, according to the American Cancer Society, Non-Hodgkin’s lymphoma is one of the common types of cancer in the U.S, accounting for 4%. Increasing awareness about early diagnosis among patients is expected to be one of the key driving forces for the hematology analyzers market.

Strategizing The Moves For The Next Decade? See Through Sample Of Hematology Analyzers Market Report! https://www.persistencemarketresearch.co/samples/16510

Companies covered in Hematology Analyzers Market Report

  • SYSMEX CORPORATION
  • Abbott Laboratories
  • Beckman Coulter Inc
  • Siemens AG
  • Boule Diagnostics AB.
  • Nihon Kohden Corporation
  • Mindray
  • HORIBA Ltd.
  • Diatron
  • Cellavision
  • Edan Instrumnets, Inc
  • SAMSUNG
  • Biosystems SA
  • F. Hoffmann-La Roche Ltd.
  • Shenzhen Dymind Biotechnology Co. Ltd.
  • PZ CORMAY SA
  • PixCell
  • Shenzhen Landwind Insdustry Co. Ltd.
  • Rayto Life and Analytical Sciences Co. Ltd
  • Shenzen Prokan Electronics Inc.

Starting With The New Decade On A Diligent Note In The Hematology Analyzers Market? https://www.persistencemarketresearch.co/methodology/16510

Persistence Market Research predicts that the global hematology analyzers market will exhibit a 5% CAGR during the forecast period (2020-2030).

Key Takeaways from Hematology Analyzers Market Study     

  • 5-part hematology analyzers are expected to be the most prominently used type of analysers across the world, holding over 3/4 of the market share in 2020.
  • With point of care testing on the rise, point of care hematology analyzers are expected to grow at a rapid pace compared to standalone devices through the forecast period.
  • Hospitals will continue to be a dominant end user in the hematology analyzers market, followed by blood banks and diagnostic centers.
  • While North America holds the largest chunk of the hematology analyzers market share by region, East Asia is expected to rapidly advance in this market space.
  • The COVId-19 pandemic will have a low to moderate adverse impact on the growth of the global hematology analyzers market.

“Rising preference for automation and point of care devices will directly support increased penetration of the hematology analyzers market across all end users,” says a PMR analyst.

How About Obtaining Insights About The Region To Enter Concerning The Hematology Analyzers Market? Press The “Purchase Now” Button To Have Our Hematology Analyzers Market Report! https://www.persistencemarketresearch.com/checkout/16510

Key Strategies amongst Players in Hematology Analyzers Market

Companies largely gain their competitive advantage and economic benefits from innovation. Innovation is advantageous and helps in acquiring new markets, generates revenues, and creates customer value propositions. Innovation contributes to higher productivity, lower costs, increased profits, and improves existing product lines and processes. Firms that innovate have a higher global market share, higher penetration rates, and higher profitability. Innovative products also attract more customers. The hematology analyzers market has also seen a similar trend since the past decade.

  • For instance, in December 2014, Sysmex launched XN-L Series hematology analyzers to help physicians detect malignant cells.
  • Similarly, in April 2016, Horiba launched a new product, Yumizen H500, a 6-part differential hematology analyzer with an artificial intelligence system, including automatic start up and shutdown. It simultaneously counts blood cells and C-reactive protein (CRP – produced by the body in response to internal inflammation).
  • The trend continues with the 2020 launch of Beckman Coulter, a DxH 690T tabletop hematology analyzer that support the Early Sepsis Indicator test identified in patients suffering from sepsis.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the hematology analyzers market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of product (3-part differential analyzers, 5-part differential analyzers, and others), modality (standalone and point of care), and end user (hospitals, diagnostic centers, ambulatory surgical centers, and blood banks), across seven key regions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Autologous Conditioned Plasma Therapy Market To Ruffle Healthy Feathers Between 2020 to 2030 Wed, 14 Apr 2021 15:27:01 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702532.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702532.html persistencemarketresearch persistencemarketresearch

Increasing geriatric population and their preference for minimally-invasive / non-surgical treatments over surgical treatments is giving impetus to the growth of the autologous conditioned plasma therapy market. Autologous conditioned plasma therapy is an efficient, simple, and minimally-invasive method that denotes an appropriate biological approach for ensuring tissue healing in a very short period of time. This therapy is used extensively across Europe and the U.S. for the treatment of orthopaedic-related injuries, and is now becoming popular across other regions as well.

Persistence Market Research predicts that, the global autologous conditioned plasma therapy market will exhibit an impressive CAGR of 11% over the forecast period (2020-2030), to be valued at around US$ 1.2 Bn by the end of 2030.

How About Looking Through The Sample Of Autologous Conditioned Plasma Therapy Market Report? https://www.persistencemarketresearch.co/samples/32152

Companies covered in Autologous Conditioned Plasma Market Report

  • Zimmer Biomet Inc.
  • Terumo Corporation
  • DePuy Synthes, Inc. (DePuy Mitek Sports Medicine)
  • AdiStem Ltd.
  • Arthrex, Inc.
  • Stryker Corporation
  • Cesca Therapeutics, Inc.
  • Biotechnology Institute BTI
  • Dr. PRP America LLC
  • EmCyte Corporation
  • Vivostat A/S
  • Regen Lab SA
  • Royal Biologics
  • Exactech, Inc.
  • Plateltex S.R.O.

How About Step-By-Step Insights To Autologous Conditioned Plasma Therapy Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.co/methodology/32152

Key Takeaways from Autologous Conditioned Plasma Therapy Market Study      

  • By composition, pure platelet-rich fibrin (P-PRF) is expected to dominate the global autologous conditioned plasma therapy market during the forecast period, owing to high efficacy of the composition in accelerating healing.
  • In terms of source, the autologous platelet-rich plasma segment is expected to gain more than 3/4 of the autologous conditioned plasma therapy market share by 2030. Preference for the autologous platelet-rich plasma source is due to less immune reaction and side effects.
  • By indication, cosmetic surgery is expected to hold a major revenue share in the global autologous conditioned plasma therapy market, owing to the rising trend for facial appearance enhancement treatments.
  • Under the end user segmentation, specialty clinics and orthopaedic & trauma centres are expected to collectively gain more than 2/3 of the market share by 2030.
  • North America is the highest revenue generating market by region due to the launch of new products and rising adoption of PRP therapies in orthopedic surgeries, with an increasing elderly population.
  • The COVID-19 pandemic has negatively impacted the global autologous conditioned plasma therapy market. Due to the outbreak, many companies are focusing on finding a possible treatment / vaccine for COVID-19. Also, as the spread of coronavirus is increasing, manufacturing industries are being shut around the world due to global restrictions, causing an unusual technology and business model transformation.

“Rising prevalence of orthopedic conditions along with increasing utilization of platelet-rich plasma in cosmetic surgeries are expected to propel the growth of the global autologous conditioned plasma therapy market,” says a PMR analyst.

Want To Keep A Tab On The Latest Findings In The Autologous Conditioned Plasma Therapy Market? Purchase Our Autologous Conditioned Plasma Therapy Market Report Now! https://www.persistencemarketresearch.com/checkout/32152

Business Strategies by Market Leaders Coupled with Improved Healthcare Access to Drive Market Growth

Increasing investments in the healthcare sector in emerging countries are anticipated to boost the global autologous conditioned plasma therapy market in these regions. Leading manufacturers in the global autologous conditioned plasma therapy market are extensively focusing on expansion of their product portfolios by undergoing new product developments and approvals, and entering into collaborations, mergers, and acquisitions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Surgical and Respiratory Masks Market To Traverse The Exponential Growth Trajectory Between 2020 to 2030 Wed, 14 Apr 2021 15:26:39 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702531.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702531.html persistencemarketresearch persistencemarketresearch

Surgical and respiratory masks are playing a crucial role during the COVID-19 pandemic and for the prevention of other diseases too. These masks are the most effective and economic non-pharmaceutical intervention measure to curb the spread of infection, which has been made mandatory to wear in public by various governments.

Surgical masks are an inevitable requirement in hospitals, and respiratory masks provide high-end protection from pathogenic microbes and viruses, which eventually contrives toward massive demand from public and healthcare workers. Escalated production, mass procurements, recent product launches, and innovative features by key players are major factors anticipated to fuel market growth. The global surgical and respiratory masks market is expected to expand at an impressive CAGR of 8% during the forecast period of 2020 to 2030, to be valued around US$ 6.7 Bn by 2030.

Planning Forward? Access Sample Of Surgical and Respiratory Masks Market Report! https://www.persistencemarketresearch.co/samples/32047

Companies covered in Surgical And Respiratory Masks Market Report

  • 3M
  • Smith & Nephew Plc.
  • Medline Industries
  • Honeywell International Inc.
  • Inspired Medical
  • Well Lead Medial Co Ltd.
  • Medtronic Plc
  • Crosstex International
  • Cardinal Health
  • Kimberly-Clark Worldwide, Inc.
  • Alpha Pro Tech
  • Ansell Ltd.
  • Halyard Health
  • Dynarex Corporation
  • DuPont

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Surgical and Respiratory Masks Market? https://www.persistencemarketresearch.co/methodology/32047

Key Takeaways from Surgical and Respiratory Masks Market Study

  • Respirators contributed for a larger revenue share than surgical masks in the global surgical and respiratory masks market in 2019, owing to their advanced filters, high adoption rate, high-end protection from viruses and toxic gases, and higher cost.
  • Reusable surgical and respiratory masks are anticipated to grab notable share in the usage segment due to their massive acceptance, cost-effectiveness, and eco-friendly nature.
  • Institutional sales held more than half of the value share of the distribution channels in the global surgical and respiratory masks market, due to preference for their quality and originality.
  • North America dominates the revenue share of the global surgical and respiratory masks market, and is expected to be more lucrative with massive demand for surgical and respiratory masks to prevent contagious respiratory diseases.
  • Global downturns, looming economy, high expenses of masks, counterfeit respirators, and scarce availability are anticipated to decelerate the growth of the global surgical and respiratory masks market.
  • The COVID-19 outbreak has rocked the growth of the global surgical and respiratory masks market, driven by massive demand for these masks for protection purposes.

“Massive demand driven by the COVID-19 pandemic and other chronic diseases, along with product launches by key players to provide advanced and safer protection are projected to propel the growth of the global surgical and respiratory masks market,” says a PMR analyst.

Planning To Introduce An Offbeat Product/Technology In The Surgical and Respiratory Masks Market? Go To “Purchase Now” To Have Our Surgical and Respiratory Masks Market Report! https://www.persistencemarketresearch.com/checkout/32047

Consolidation Activity – Imperative Strategy followed by Market Players

The global surgical and respiratory masks market is experiencing consolidation activities by manufacturers, which include collaborations, acquisitions, and partnerships. Manufacturers have deliberated focus on expanding production capacity to deliver massive number of units in lesser time. For instance, on 14th April 2020, 3M collaborated with Cummins to elevate the production of powered-air purifier respirators to fulfil the massive demand for respirators.

What else is in the report?

Persistence market research offers actionable insights and a unique perspective on the surgical and respiratory masks market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020–2030, based on product type (surgical masks and respirators), usage (reusable and disposable), and distribution channels (institutional sales and retail sales), across seven key regions. By product type, surgical masks are further segmented into basic surgical masks, anti-fog foam surgical masks, fluid/splash resistant surgical masks and others; and respirators are further segmented into single strap masks, filter dust masks, half-face masks, full-face masks, and PAPRs. By distribution channel, institutional sales are further segmented into hospitals, ambulatory surgical centers, office-based clinics, skilled nursing facilities, diagnostic laboratories, and academic and research institutes.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Indwelling Catheters Market To Resonate With Growth Between 2020 to 2030 Wed, 14 Apr 2021 15:26:17 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702530.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702530.html persistencemarketresearch persistencemarketresearch

Advancements in material used for the manufacturing of indwelling catheters plays a significant role in the success of clinical catheterization and high patient convenience. Leading industry players are developing innovative material for manufacturing indwelling catheters of superior quality, performance, and patient ease. Material properties such as high resistance to collapse, minimal trauma to lumen wall, and low accumulation and occlusion are significantly focused attributes during the development and commercialization of indwelling catheters by key industry players. In addition, technological advancements such as 3– and 4-way indwelling urinary catheters provide simultaneous systemic and distal perfusion.

Key players operating in the indwelling catheters market offer a wide range of urinary incontinence products such as long-term and short-term indwelling catheters. Increase in prevalence of surgeries in hospitals is expected to boost the demand for indwelling catheters in the global market. Demand for urinary incontinence products has increased to prevent infection spread in hospitals, home care centers, surgical centers, etc., creating an absolute opportunity for the growth of the indwelling catheters market.

PMR predicts that the global indwelling catheters market is expected to reach US$ 12.7 Bn in 2030, and is expected to exhibit a CAGR of over 6% during the forecast period (2020–2030).

How About Looking Through The Sample Of Indwelling Catheters Market Report? https://www.persistencemarketresearch.co/samples/32043

Companies covered in Indwelling Catheters Market Report

  • Teleflex Incorporated
  • Cardinal Health
  • B. Braun Melsungen AG
  • Coloplast
  • Medtronic
  • ConvaTec, Inc.
  • Sterimed Group
  • Becton, Dickinson and Company
  • McKesson Medical
  • Poiesis Medical
  • COOK Medical
  • Smiths Medical
  • Rocket Medical plc.

How About Step-By-Step Insights To Indwelling Catheters Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.co/methodology/32043

Key Takeaways from Indwelling Catheters Market Study         

  • By product, peripheral intravenous catheters are expected to gain traction in the global indwelling catheters market during the forecast period.
  • There is extensive use of peripheral intravenous catheters in hospitals and surgical centers for intravenous therapy during or after a surgery.
  • In terms of material, the Tetrafluorethylene-hexafluoropropylene (Teflon) segment is expected to gain more than half of the market value share during the forecast period.
  • Based on packaging segment, single strip packs are expected to hold nearly one-third of the market share due to higher demand for single strip packs over kit packs.
  • As per end user, hospitals lead the segment and are expected to collectively gain more than half of market share value in the indwelling catheters market during 2020-2030.
  • North America holds the highest revenue share by region due to high rate of hospitalizations, and contributes around 1/3 of the market share, owing to rise in number of patients and higher adoption of indwelling catheters. Europe is expected to offer lucrative opportunities owing to rise in demand for indwelling catheters across hospitals, nursing homes, and surgical centres.

“Rising prevalence of urological disorders and technological advancements are expected to drive growth of the global indwelling catheters market,” says a PMR analyst.

Want To Keep A Tab On The Latest Findings In The Indwelling Catheters Market? Purchase Our Indwelling Catheters Market Report Now! https://www.persistencemarketresearch.com/checkout/32043

Innovative Product Approvals – Key Strategy Embraced by Industry Players

Development and approval of technologically-advanced indwelling catheters with multiple functionalities are focused on by specialized developers and suppliers in the indwelling catheters market to strengthen their product portfolios in this time of high competitiveness. In addition, inorganic growth strategies such as acquisitions and product in-licencing are targeted by leading players in the indwelling catheters market.

COVID-19 Pandemic to Reduce Demand for Indwelling Catheterization at Healthcare Facilities

The outbreak of the novel coronavirus is expected to hamper indwelling catheterization procedures in hospitals, ambulatory surgical centers, and clinics. This short-term considerable decline in the number of indwelling catheterization is likely to hit demand in the indwelling catheters market. This highly-transmissible respiratory disease has significantly reduced hospitalization cases and surgical procedures due to fear of infection among hospitalized patients.

For instance, in 2020, a study was conducted in Italy to understand the impact of COVID-19 on hospitalization rates for acute coronary syndrome (ACS) in Northern Italy. The study found that, hospitalization rates decreased significantly by 10-30%. This significant reduction in hospitalization and subsequent catheterization procedures are expected to hamper the growth of the indwelling catheters market during the COVID-19 crisis.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the indwelling catheters market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of product (indwelling urinary catheters, indwelling pleural catheters, indwelling peritoneal catheters, indwelling nephrostomy catheters, and peripheral intravenous catheters), material (latex, PVC, silicone, Tetrafluorethylene-hexafluoropropylene [Teflon], and others), packaging (single strip packs and kit packs), and end user (hospitals, ambulatory surgical centres, long-term care centres, and home care), across seven key regions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Disinfection Robots Market To Surpass Covid-19 Cringe From 2020 to 2030 Onwards Wed, 14 Apr 2021 15:25:54 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702529.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702529.html persistencemarketresearch persistencemarketresearch

Adoption of disinfection robots has increased rapidly after the outbreak of COVID-19. There has been an increase in the sale of disinfection robots by 400-600% across the globe. The novel coronavirus outbreak has also highlighted the inability of conventional techniques in disinfecting and sanitizing a facility, and this factor has rapidly driven the adoption of disinfection robots, as these robots can effectively disinfect hospitals and other public areas with minimal human interference.

Many companies have got a stamp of approval for their products to fight the COVID-19 battle. Approvals for different products further enhances the attention given by end users. Many providers of disinfection services have entered the disinfection robots market, and many more are coming in with their innovative and advanced technologies and software. With the coronavirus outbreak, manufacturers of disinfection robots will be able to cash in on vast opportunities to make their business stand out from competitors by coming up with a broad range of products.

As per PMR analysis, the global disinfection robots market is set to surge at a high CAGR of 27% over the next ten years, expanding 10X in value over the same period of time.

Get Going With Sample Of Disinfection Robots Market Report! https://www.persistencemarketresearch.co/samples/22822

Companies covered in Disinfection Robot Market Report

  • Xenex Disinfection Services, LLC
  • Nevoa Inc.
  • Ultraviolet Devices, Inc.
  • Rubedo Sistemos
  • Blue Ocean Robotics ApS
  • Bioquell, Inc.
  • Skytron, LLC.
  • The Clorox Company (Procter & Gamble)
  • OMRON Corporation
  • Fetch Robotics, Inc.
  • Geek+
  • Akara Robotics Ltd.
  • FINSEN TECHNOLOGIES LTD.
  • TMI Robotics Co., Ltd
  • SESTO Robotics
  • OTSAW

How About Re-Inventing The Methodical Wheel In The Disinfection Robots Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.co/methodology/22822

Key Takeaways from Disinfection Robots Market Study

  • Based on product, with market value share of over 3/4, UV light robots will be the most profitable segment, due to higher adoption coupled with superior disinfection efficacy as compared to hydrogen peroxide vapor (HPV) robots.
  • In terms of technology, fully autonomous robots is the leading segment, owing to higher efficiency and low human interaction while disinfecting as compared to semi-autonomous robots.
  • North America is the most lucrative region in the global disinfection robots market, with around 45% of the market share, owing to higher adoption of these devices in the region.
  • As end users, hospitals is most profitable segment with around 2/3 of the market value share, due to higher demand for disinfection robots in order to reduce the risk of hospital-acquired infections.

“Increasing demand for disinfection robots to reduce the spread of healthcare facility-associated infections, increasing technological advancements, and growing concerns about maintaining environmental hygiene after the COVID-19 outbreak are some of the factors expected to contribute in propelling the growth of the global disinfection robots market for years to come,” says a PMR analyst.

Keeping A Tab On Key Players In The Disinfection Robots Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Disinfection Robots Market Report! https://www.persistencemarketresearch.com/checkout/22822

Key Strategy amongst Market Players

Key players in the disinfection robots market focusing on strengthening their market presence through a variety of advanced technologies and software with the development of new platforms. Manufacturers are highly focusing on developing products to meet every budget of end users. Leading players are trying to provide their products in middle and lower income countries, and local players are focusing on increasing their product reach with the launch of various types of disinfection robots. Market players are focusing on launching facility-specific disinfection robots in order to enhance the efficacy of disinfection procedures and increasing the adoption of their products.

Growing Trends in Disinfection Robots Market Space

Manufacturers in the disinfection robots market space are highly focusing on developing facility-specific disinfection robots for reducing the cost of manual cleaning, such as robots for commercial spaces and offices. Companies are understanding the demands of various end users and are effectively providing their services based on applications. Manufacturers are modifying predesigned medical robots, such as with the use of UV technology. UV light can be combined with mobile robots to make disinfection services autonomous and more efficient. These trends are expected to boost the growth of the disinfection robots market over the forecast period of 2020 to 2030.

What else is in the report?

Persistence Market Research offers a unique perspective and actionable insights on the disinfection robots market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030 based on product (hydrogen peroxide vapor (HPV) robots and UV light robots), technology (semi-autonomous robots and fully-autonomous robots), and end user (hospitals, clinics & emergency care centers, diagnostic laboratories, pharmaceutical & biotech companies, airports, railway stations, shopping malls, production facilities, office buildings, and others), across seven key regions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Phenylketonuria Treatment Market To Witness A Growth Of 7%, To Reach Tue, 13 Apr 2021 17:57:18 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702302.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702302.html persistencemarketresearch persistencemarketresearch

Phenylketonuria (PKU) is an inherited disorder caused by excess of phenylalanine in the blood, which can lead to severe intellectual disabilities. There is no cure for phenylketonuria as yet, and dietary management is the only option to maintain the phenylalanine level in the body. Untreated infants with PKU tend to have unusually light eye, skin, and hair colour due to excess of phenylalanine levels interfering with melanin. Neurological symptoms such as seizures, abnormal muscle movement, tremors, or involuntary movement are some of the symptoms mainly observed in such patients.

Rising prevalence of phenylketonuria among newborns and surging demand for novel formulations to treat the disease have led to increased opportunities for market players. Stakeholders are investing more in research & development for novel treatment solutions within the nutraceutical industry.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/14410

Companies covered in Phenylketonuria Treatment Market Report

  • Arla Foods Ingredients Group P/S
  • Archer Daniels Midland Company
  • BASF SE
  • Chr. Hansen
  • Cargill, Incorporated
  • Seidler Chemical Co, Inc.
  • Nestlé S.A. (Vitaflo International)
  • Reckitt Benckiser Group plc. (Mead Johnson & Company, LLC.)
  • Abbott Laboratories
  • APR Applied Pharma Research S. A.
  • Ajinomoto Co., Inc.
  • VitafriendsPKU
  • Pristine Organics Pvt. Ltd

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/14410

According to the latest report published by Persistence Market Research, the global phenylketonuria treatment market for protein ingredients was valued at US$ 325.9 Mn in 2019, and is predicted to witness an impressive CAGR of over 6% during the forecast period (2020–2030). Similarly, the market for finished products was valued at US$ 565.8 Mn in 2019, and is predicted to witness an impressive CAGR of around 7% through 2030.

Key Takeaways from Phenylketonuria Treatment Market Study       

  • For Protein Ingredients
    • Essential and non-essential amino acid ingredients are expected to contribute more than 1/3 of the revenue share in the market.
    • Powder blend form is expected to gain traction in phenylketonuria treatment, accounting for more than 90% share throughout the forecast years.
    • By targeted customer, consumer healthcare companies hold the highest share of more than 80% in this space.
    • By sales channel, industry sales of protein ingredients are dominating the market.
    • North America holds the highest share in the global phenylketonuria treatment market, owing to the presence of big market players and growing research & development efforts in the region.
    • Key players are focused on expanding their product portfolios and expansion at regional levels through collaborations and acquisitions.
    • The market in the U.S. is projected to be the fastest-growing at a CAGR above 6.5% through 2030. The U.S. holds a big portion of the market revenue and accounts for more than 90% in North America.
  • For Finish Products
    • Essential and non-essential amino acids are expected to contribute more than 1/3 of the revenue share in the market.
    • The powder & granules form is expected to dominate phenylketonuria treatment, accounting for a share of more than 50% through 2030.
    • By targeted customer, adults account for the highest market share of more than 50%.
    • By sales channel, hypermarkets and supermarkets will hold the highest share throughout the forecast period.
    • North America holds more than 40% of the global phenylketonuria treatment market share.
    • Key market players are focusing on expansion of their product portfolios by highly investing in the research & development sector, and are generating high revenue through collaborations and acquisitions.
    • The market in the U.S. is projected to be the fastest-growing, and will expand at a CAGR close to 6% through 2030. The U.S. holds a big portion of the market revenue, and accounts for more than 90% share in North America.

“Increasing prevalence of PKU and rising adoption of PKU diets will upswing the global phenylketonuria treatment market over the coming years,” says an analyst of Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/14410

Collaborations & Acquisitions Key Strategies amongst Market Players

Prominent players in the phenylketonuria treatment market are firming their product ranges through acquisitions and reaching out to emerging markets. Increasing investments and manufacturing capacity expansion are expected to favour growth of the global market over the forecast period.

  • For instance, Mead Johnson Nutrition Company was acquired by the Reckitt Benckiser Group plc (RB). Mead Johnson is now a division of RB, adding its globally-recognized brands, including Phenyl-Free® 1, an iron-fortified PKU infant formula and medical food powder for infants and young children with documented phenylketonuria.
  • Additionally, Abbott Laboratories collaborated with Syngene to inaugurate its first nutrition research & development centre in India.

Various players in the phenylketonuria treatment market are focusing on research & development, product launches, and advanced solutions to strengthen and expand their product portfolios.

  • For instance, Vitaflo USA introduced PKU Sphere™, a powdered, low phenylalanine medical food used in the dietary management of phenylketonuria. The medical food formula is a Glycomacropeptide (GMP)-based medical food containing a balanced mix of GMP and amino acids.
  • Ajinomoto Co., Inc. introduced a new product line, Glytactin BUILD 20/20™ and Glytactin RTD Lite,  new PKU formulas featuring the next generation of Glytactin with 40% less Phe per gram of PE than all other GMP-based PKU medical foods.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the phenylketonuria treatment market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030. The research study is based on PKU ingredients (protein ingredient [Glycomacropeptide (GMP) and essential and non-essential amino acids] and finish products [Glycomacropeptide (GMP) and essential and non-essential amino acids]), targeted customer (protein ingredients [consumer healthcare companies, pharmaceutical companies, and contract manufacturing companies (CMOs)] and finish products [adults, paediatrics, and pregnant women]), form (protein ingredients [powder blend and granules], finish products [powder & granules, tablets, capsules, powder sachets, ready-to-drink, shakes, and other]), and sales channel (protein ingredients [industry sales], finish products [hospital pharmacies, retail pharmacies, online pharmacies, and hypermarkets & supermarkets]), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Phenylketonuria Treatment Market To Witness A Growth Of 7%, To Reach Tue, 13 Apr 2021 17:56:39 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702301.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702301.html persistencemarketresearch persistencemarketresearch

Phenylketonuria (PKU) is an inherited disorder caused by excess of phenylalanine in the blood, which can lead to severe intellectual disabilities. There is no cure for phenylketonuria as yet, and dietary management is the only option to maintain the phenylalanine level in the body. Untreated infants with PKU tend to have unusually light eye, skin, and hair colour due to excess of phenylalanine levels interfering with melanin. Neurological symptoms such as seizures, abnormal muscle movement, tremors, or involuntary movement are some of the symptoms mainly observed in such patients.

Rising prevalence of phenylketonuria among newborns and surging demand for novel formulations to treat the disease have led to increased opportunities for market players. Stakeholders are investing more in research & development for novel treatment solutions within the nutraceutical industry.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/14410

Companies covered in Phenylketonuria Treatment Market Report

  • Arla Foods Ingredients Group P/S
  • Archer Daniels Midland Company
  • BASF SE
  • Chr. Hansen
  • Cargill, Incorporated
  • Seidler Chemical Co, Inc.
  • Nestlé S.A. (Vitaflo International)
  • Reckitt Benckiser Group plc. (Mead Johnson & Company, LLC.)
  • Abbott Laboratories
  • APR Applied Pharma Research S. A.
  • Ajinomoto Co., Inc.
  • VitafriendsPKU
  • Pristine Organics Pvt. Ltd

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/14410

According to the latest report published by Persistence Market Research, the global phenylketonuria treatment market for protein ingredients was valued at US$ 325.9 Mn in 2019, and is predicted to witness an impressive CAGR of over 6% during the forecast period (2020–2030). Similarly, the market for finished products was valued at US$ 565.8 Mn in 2019, and is predicted to witness an impressive CAGR of around 7% through 2030.

Key Takeaways from Phenylketonuria Treatment Market Study       

  • For Protein Ingredients
    • Essential and non-essential amino acid ingredients are expected to contribute more than 1/3 of the revenue share in the market.
    • Powder blend form is expected to gain traction in phenylketonuria treatment, accounting for more than 90% share throughout the forecast years.
    • By targeted customer, consumer healthcare companies hold the highest share of more than 80% in this space.
    • By sales channel, industry sales of protein ingredients are dominating the market.
    • North America holds the highest share in the global phenylketonuria treatment market, owing to the presence of big market players and growing research & development efforts in the region.
    • Key players are focused on expanding their product portfolios and expansion at regional levels through collaborations and acquisitions.
    • The market in the U.S. is projected to be the fastest-growing at a CAGR above 6.5% through 2030. The U.S. holds a big portion of the market revenue and accounts for more than 90% in North America.
  • For Finish Products
    • Essential and non-essential amino acids are expected to contribute more than 1/3 of the revenue share in the market.
    • The powder & granules form is expected to dominate phenylketonuria treatment, accounting for a share of more than 50% through 2030.
    • By targeted customer, adults account for the highest market share of more than 50%.
    • By sales channel, hypermarkets and supermarkets will hold the highest share throughout the forecast period.
    • North America holds more than 40% of the global phenylketonuria treatment market share.
    • Key market players are focusing on expansion of their product portfolios by highly investing in the research & development sector, and are generating high revenue through collaborations and acquisitions.
    • The market in the U.S. is projected to be the fastest-growing, and will expand at a CAGR close to 6% through 2030. The U.S. holds a big portion of the market revenue, and accounts for more than 90% share in North America.

“Increasing prevalence of PKU and rising adoption of PKU diets will upswing the global phenylketonuria treatment market over the coming years,” says an analyst of Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/14410

Collaborations & Acquisitions Key Strategies amongst Market Players

Prominent players in the phenylketonuria treatment market are firming their product ranges through acquisitions and reaching out to emerging markets. Increasing investments and manufacturing capacity expansion are expected to favour growth of the global market over the forecast period.

  • For instance, Mead Johnson Nutrition Company was acquired by the Reckitt Benckiser Group plc (RB). Mead Johnson is now a division of RB, adding its globally-recognized brands, including Phenyl-Free® 1, an iron-fortified PKU infant formula and medical food powder for infants and young children with documented phenylketonuria.
  • Additionally, Abbott Laboratories collaborated with Syngene to inaugurate its first nutrition research & development centre in India.

Various players in the phenylketonuria treatment market are focusing on research & development, product launches, and advanced solutions to strengthen and expand their product portfolios.

  • For instance, Vitaflo USA introduced PKU Sphere™, a powdered, low phenylalanine medical food used in the dietary management of phenylketonuria. The medical food formula is a Glycomacropeptide (GMP)-based medical food containing a balanced mix of GMP and amino acids.
  • Ajinomoto Co., Inc. introduced a new product line, Glytactin BUILD 20/20™ and Glytactin RTD Lite,  new PKU formulas featuring the next generation of Glytactin with 40% less Phe per gram of PE than all other GMP-based PKU medical foods.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the phenylketonuria treatment market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030. The research study is based on PKU ingredients (protein ingredient [Glycomacropeptide (GMP) and essential and non-essential amino acids] and finish products [Glycomacropeptide (GMP) and essential and non-essential amino acids]), targeted customer (protein ingredients [consumer healthcare companies, pharmaceutical companies, and contract manufacturing companies (CMOs)] and finish products [adults, paediatrics, and pregnant women]), form (protein ingredients [powder blend and granules], finish products [powder & granules, tablets, capsules, powder sachets, ready-to-drink, shakes, and other]), and sales channel (protein ingredients [industry sales], finish products [hospital pharmacies, retail pharmacies, online pharmacies, and hypermarkets & supermarkets]), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Autogenous Vaccines Market To Sabotage Covid-19 With A CAGR Of 4.4% Tue, 13 Apr 2021 17:56:17 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702300.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702300.html persistencemarketresearch persistencemarketresearch

Vaccination of animals is an essential part of animal health management. It helps to boost the immune system and keep animals safe from various bacterial and viral infections. Autogenous vaccines are most preferred for animal vaccination purposes. Federal guidelines state that an autogenous vaccine is made from a bacterial or viral strain of the diseased animal. Products made from these strains can only be marketed by veterinarian or farm owners from where they were isolated.

Over the years, there has been growing demand for autogenous vaccines that are derived from bacterial strains, owing to their greater efficacy as compared to viral strains. Salmonella, Staphylococcus, Haemophilus, and Mycoplasma are some of the commonly used bacterial strains to develop autogenous bacterial vaccines. Growing prevalence of bacterial infections among animals, preference toward autogenous vaccines over antibiotics, and increased funding and support for international animal disease eradication are likely to upswing demand for autogenous bacterial vaccines over the coming years.

According to a revised report published by Persistence Market Research, the autogenous vaccines market was valued over US$ 116 Mn in 2020, and is predicted to witness an impressive CAGR of 5.5% over the forecast period (2021-2031).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/29491

Companies covered in Autogenous Vaccines Market Report

  • Newport Laboratories, Inc. (Boehringer Ingelheim International GmbH)
  • Phibro Animal Health
  • Elanco Animal Health
  • Ceva Santé Animale
  • ACE Laboratory Services (Apiam Animal Health)
  • Huvepharma, Inc.
  • AniCon Labor GmbH
  • Cambridge Technologies
  • Dyntec s. r. o
  • Hygieia Biological Laboratories
  • HIPRA
  • Vaxxinova
  • sanphar (ipeve)
  • Addison Biological Laboratory
  • Zoetis (PHARMAQ AS)
  • Barramundi Asia Pte Ltd.(UVAXX Asia)
  • Kennebec River Biosciences

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/29491

 Key Takeaways from Market Study

  • By type of strain, bacterial autogenous vaccines are expected to contribute to more than 1/3 revenue share in the market.
  • By end user, livestock farming companies will lead by acquiring over 45% of market share. This sector has witnessed the most adoption of autogenous vaccines as compared to other end users.
  • Europe holds around half of the global market share.
  • Key players are focused on expanding their product portfolios and expansion at regional levels through collaborations and acquisitions.
  • COVID-19 outbreak in big economies is expected to negatively impact demand for autogenous vaccines owing to reduced healthcare center visits. Impact was also observed on vaccine production and transportation owing to travel restriction and lack of workforce at production centers.
  • The market in Thailand is projected to be the fastest-growing in the Asia Pacific region, and will expand at a CAGR above 5% through 2031.
  • The U.S. market holds a big portion of revenue, and its market share accounts for more than 90% in North America.

“Increasing preference for autogenous vaccines over antibiotics will catalyze market growth over the coming years,” says an analyst of Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/29491

Collaborations & Acquisitions Key Strategies amongst Market Players

Prominent players manufacturing autogenous vaccines are collectively increasing their product ranges through strategic initiatives such as acquisitions and reaching out to emerging markets. Increasing investments and manufacturing capacity expansion are expected to favour market growth over the forecast period.

For instance,

  • In September 2019, Agri Labs (Huvepharma, Inc.) established a new fermentation plant in Peshtera, Southern Bulgaria.
  • In May 2017, Elanco Animal Health opened a new manufacturing facility for autogenous poultry vaccines in Winslow, Maine.
  • Agreement to acquire Bayer AG‘s animal health business by Elanco Animal Health in August 2019 is one of the major acquisitions in this space. This strategic move will help Elanco Animal Health enhance its market position.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the autogenous vaccines market in its latest study, presenting historical demand assessment of 2016-2020 and projections for 2021-2031, on the basis of strain (bacterial strain and viral strain) and end user (veterinary research institutes, livestock farming companies, and veterinary clinics and hospitals), across the five key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Active Pharmaceutical Ingredient Market To Rescind With A CAGR Of 4.5% Tue, 13 Apr 2021 17:55:55 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702299.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702299.html persistencemarketresearch persistencemarketresearch

Prevalence of chronic diseases is constantly on the rise across the world. This is leading to a major health burden on governments and the society in general. Out of these, cardiovascular diseases make up around half of the total deaths caused by chronic diseases. According to the World Health Organization, in 2016, ischemic heart disease and stroke accounted for around 27% of total deaths, worldwide. Chronic obstructive pulmonary disease was the third most cause of death in the same years. These non-communicable diseases were major causes of deaths globally, ranging from 37% in lower economies and 88% in countries with high income.

Rising cases of chronic diseases is surging the need for pharmaceutical products, thereby increasing the need for pharmaceutical ingredients (APIs), especially small molecules.

Persistence Market Research predicts that the global active pharmaceutical ingredients market to exhibit a CAGR above 4% over the forecast period (2021-2031).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/11260

Companies covered in Active Pharmaceutical Ingredient Marke Report

  • Pfizer Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Hepalink Group
  • Lonza
  • Merck & Co. Inc.
  • Sandoz International GmbH
  • Aurobindo Pharma Limited
  • Fresenius Kabi LLC

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/11260

Key Takeaways from Market Study   

  • Non-controlled substances hold over half of the small molecule API market share, making them the predominant growth contributing factor.
  • Pharmaceutical and biopharmaceutical companies, combined, to contribute over 70% of the market revenue.
  • Major markets for active pharmaceutical ingredients to be East Asia, South Asia, North America, and Europe.
  • China and India to be the most lucrative markets for APIs.
  • Due to the impact of COVID-19, the API market saw a slight decline in growth in 2020, at 3.4%.

“Rising prevalence of chronic disorders and increasing research on small molecule APIs are expected to propel growth of the global active pharmaceutical ingredients market over the coming years,” says a Persistence Market Research analyst.

Access Full Report @https://www.persistencemarketresearch.com/checkout/11260

Advancements in API Manufacturing

API manufacturing will require implementation of continuous new technologies and tools to speed up the process and deliver consistent quality products. Hence, major players are highly focused on the production of optimized APIs with technological advancements in processes such as powder handling, lyophilization, process control, continuous flow chemistry, and process control.

Rise in Outsourcing to Merchant Companies

Even if big pharma players have established facilities for the production of APIs and pharma products, the trend of outsourcing is still on the rise. Many companies are outsourcing their requirements to cut costs on expensive equipment, manpower, and infrastructure. It is estimated that 40% of pharma products are manufactured by third-party vendors.

  • For instance, AstraZeneca used to have several manufacturing centers in North America, but currently, only 15% of its APIs are made in-house, and the company is looking to outsource all manufacturing overseas. From the last 20 years or so, directly sourcing APIs from China and India has increased due to the production capabilities of these countries. Also, stringent regulations in the West have attracted companies toward China and India.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the active pharmaceutical ingredients (API) market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031, on the basis of API (small molecules [controlled substances {natural opioids and semi-synthetic/synthetic opioids}, non-controlled substances {NSAIDs, anti-infective, antimicrobial, oral anti-diabetics, anti-hypertensive, and others}, and HPAPI], peptides & oligonucleotides, carbohydrate drugs, and steroidal drugs), end user (contract manufacturing organizations (CMOs), pharmaceuticals, contract development & manufacturing organizations (CDMOs), and compounding pharmacies), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Newborn Metabolic Screening Market To Witness A Penurious CAGR Of 9.2% Tue, 13 Apr 2021 17:55:32 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702297.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702297.html persistencemarketresearch persistencemarketresearch

Increasing birth rates across the world are expected to drive demand for newborn metabolic screening, as the risk of galactosemia, sickle cell disease, phenylketonuria, maple syrup urine disease, and cystic fibrosis is higher among infants. Various countries are implementing screening for metabolic diseases in newborns as a part of their immunization programs. To remain competitive and ensure a robust product pipeline, leading companies continue to identify potential assets through pilot screening programs, which typically have limited resources to see projects through the market.

According to a latest report published by Persistence Market Research, the global newborn metabolic screening market was valued around US$ 247 Mn in 2020, and is expected to witness an impressive CAGR of over 9% during the forecast period (2020 – 2030).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/31998

Companies covered in Newborn Metabolic Screening Market Report

  • PerkinElmer
  • Bio-Rad Laboratories
  • Trivitron Healthcare Private Limited
  • BioMedomics, Inc.
  • Luminex Corporation
  • MP BIOMEDICALS
  • Synergy Medical Systems LLP
  • Agilent Technologies, Inc
  • Thermo Fisher Scientific, Inc
  • Zivak Technologies

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/31998

 Key Takeaways from Market Study  

  • Sickle cell disease is expected to contribute more than 30% of revenue share to the market.
  • By sample, blood testing held the highest market share in 2019 due to efficient diagnostic results.
  • Europe holds a significant share of over 30% in the global newborn metabolic screening market.
  • Leading manufacturers are focused on strengthening their product portfolios and regional expansion through collaborations.
  • Hospitals are expected to hold significant market share, due to high number of screening programs being arranged in collaboration with hospitals.
  • The COVID-19 outbreak has had a negative impact on the market, as short-term lockdowns disturbed the production and supply chain of kits.
  • The market in the U.S is projected to expand at a CAGR of close to 10% through 2030.
  • The U.K market has a share of more than 17% in Europe, and is expected to progress at a CAGR of more than 12% over the next ten years.

“Increasing prevalence of new born metabolic diseases and rising adoption of related screening program will boost the global market,” says an analyst of Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/31998

Collaborations & Acquisitions Key Strategies amongst Market Players

Leading players in the newborn metabolic screening landscape are focusing on improving their product portfolios through partnerships and acquisitions. Various players are also focusing on regulatory approvals and innovative product launches.

  • On October 05, 2020, PerkinElmer announced CE-IVD approval of the EONIS™ newborn screening assay.
  • In October 2018, Trivitron’s Labsystems Diagnostics launched high quality newborn screening panels.
  • On September 3, 2020, Sickle SCAN® was approved by the Department of Health in Australia.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the newborn metabolic screening market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of test (galactosemia, sickle cell disease, cystic fibrosis, toxoplasmosis, phenylketonuria (PKU), methylmalonic acidemia, maple syrup urine disease (MSUD), tyrosinemia, citrullinemia, and Medium Chain Acyl CoA Dehydrogenase (MCAD) Deficiency), sample (blood and urine), and end user (diagnostic laboratories, specialty clinics, and hospitals), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Interventional Pulmonology Market To Register A CAGR Of 4.6% Tue, 13 Apr 2021 17:55:10 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702296.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702296.html persistencemarketresearch persistencemarketresearch

Interventional pulmonology is an area of pulmonary medicine that deals specifically with minimally invasive endoscopic and percutaneous procedures for the diagnosis and treatment of neoplastic as well as non-neoplastic diseases of the airways, lungs, and pleura. Rise in the number of COPD cases across the world is expected to boost demand over the coming years. Need for faster recovery time and reduced pain during procedures and surgeries for respiratory disorders has strengthened the market. Leading manufacturers of interventional pulmonology devices are focusing on geographical expansion to increase revenue and add new repair and service centers in emerging countries through the acquisition of local players.

Various awareness programs have been initiated by healthcare providers and health organizations/societies such as environmental programs, medication maintenance programs, and online education programs for public and healthcare professionals across the globe to control asthma, COPD, and other respiratory diseases. Major companies such as Boston Scientific Corporation, Olympus Corporation, and FUJIFILM Corporation, besides others, are focused on spreading awareness regarding respiratory diseases.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12544

Companies covered in Interventional Pulmonology Market Report

  • Medtronic Plc
  • Boston Scientific Corporation
  • Olympus Corporation
  • FUJIFILM Corporation
  • Becton, Dickinson and Company
  • Smiths Group Plc
  • Cook Medical
  • Vygon
  • Clarus Medical LLC
  • Huger Medical Instrument Co. Ltd
  • Taewoong Medical Co. Ltd.
  • Shanghai AoHua Photoelectricity Endoscope Co., Ltd
  • Karl Storz
  • Richard Wolf Corporation
  • PENTAX Medical

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12544

As per Persistence Market Research analysis, the global interventional pulmonology market is expected to exhibit a CAGR of more than 4% over the forecast period (2021 – 2031).

Key Takeaways from Study

  • IP diagnostic devices are expected to hold maximum revenue share under products.
  • Lung cancer is projected to be the dominant segment among indications, in terms of revenue. The segment accounted for 26.6% share in 2020.
  • The U.S., followed by Europe, is expected to hold substantial revenue share in the global interventional pulmonology market.
  • Emerging economies such as China, India, Brazil, Mexico, and South Africa have a large COPD patient pool, and rising disposable income of patients with increased healthcare expenditure would encourage interventional pulmonology device manufacturers to enter these markets.
  • The interventional pulmonology space faced adverse effects due to the COVID-19 crisis as a result of supply chain disruptions and economic impact of the pandemic on small- and medium-sized enterprises.
  • Hospitals and diagnostic centers to account for bulk of the market share (around ¾).

Rising global prevalence of various respiratory diseases has increased demand for effective diagnosis and treatment in order to better manage the progression rate of these diseases,” says a Persistence Market Research analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12544

Acquisitions of Small & Medium Players – Imperative Strategy for Market Players

Given the consolidation in the market, bigger players are focusing on the acquisition of small and medium market players. This trend is being observed across North America and Europe. This is dominated by players with a strong regional distribution presence in terms of direct sales force and medical ventilator product manufacturing.

What else is in the report?

Persistence Market Research offers actionable insights and unique perspective on the interventional pulmonology market in its latest study, presenting historical demand assessment of 2016 – 2019 and projections for 2021–2031, based on product (Electromagnetic Navigation Bronchoscopy (ENB), IP Diagnostic Devices, IP therapeutic devices), indication (Asthma, Lung Cancer, COPD, Foreign Body Extraction, Tracheal and Bronchial Stenosis), and end user (Hospitals, Pulmonology Clinics, Ambulatory Surgical Centers, Diagnostic Centers), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Peptone Market To Embark Upon A Double Digit CAGR 4.2% Tue, 13 Apr 2021 17:54:48 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702295.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702295.html persistencemarketresearch persistencemarketresearch

Peptones are protein hydrolysates that are widely used as a growth supplement for mammalian and microbial cell culture. These are derived from plants, animals, and yeast. However, animal-based peptones are mostly preferred for in commercial cell culture optimization processes. Availability of a wide variety of animal peptones also contributes to their high-value share in the market. Increasing adoption of animal-based peptones as a low-cost growth supplement for the commercial production of biopharmaceuticals is accelerating market growth. Further, growing biopharmaceutical manufacturing activities are also expected to accelerate the expansion of the peptone market over the forecast period of 2020 to 2030.

Growing burden of chronic disease patient population is creating huge demand for novel biopharmaceuticals. Protein supplements such as peptone play an important role in biopharmaceutical manufacturing. Due to rapid growth of the biopharmaceutical industry, demand for peptone is expected to witness significant increase over the coming years.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12784

Companies covered in Peptone Market Report

  • HiMedia Laboratories
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Biospringer
  • BD.
  • Hardy Diagnostics,
  • Solabia Group
  • Global Bioingredients,
  • Kerry Inc
  • Organotechnie
  • Nu-Tek BioScience, LLC.
  • Biotecnica

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12784

According to the latest report published by Persistence Market Research, the global peptone market was valued at US$ 130.9 Mn in 2020, and is predicted to witness a steady CAGR of over 4% during the forecast period (2020 – 2030).

 Key Takeaways from Peptone Market Study

  • Peptones derived from animals is expected to contribute more than half of the revenue share in the market.
  • By product, protein hydrolysates are expected to hold the highest market share in 2020, with more than 3/4 revenue share worldwide.
  • By end user, biopharmaceutical Companies will hold a major share by acquiring over 55% of the market. This sector is the most advancing compared to other end users.
  • By application, microbial cell culture is expected to hold two-third market share, owing to high preference for peptone supplements for microbial cell culture.
  • North America captures close to 1/3 of the global peptone market share.
  • Collaborations and acquisitions are key growth strategies of leading manufacturers for expansion of product portfolio.
  • The COVID-19 outbreak had a considerable impact on the growth of the peptone market in 2020 due to lockdown implementation by governments.
  • Country’s such as China and India are projected to be the fastest-growing markets, and will expand at a CAGR above 5% through 2030.
  • The U.S. holds a big portion of the market revenue, and accounts for more than 80% in North America.

“Increasing burden of infectious diseases and preference of peptone for bio-production will upswing global demand,” says an analyst of Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12784

Collaborations & Acquisitions Key Strategies amongst Market Players

Key players in the peptone market are distributing their product ranges through acquisitions and reaching out to emerging markets. Strategic collaborations and acquisitions of small- and mid-sized companies create long-term value and future sustainable growth for leading manufacturers, which is also expected to drive the peptone industry over the coming years.

For instance, in September 2018, Thermo Fisher Scientific acquired the advanced bioprocessing business of BD (Becton, Dickinson and Company), which is a leading provider of life science and biopharmaceutical products.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the peptone market in its latest study, presenting historical demand assessment of 2015 – 2020 and projections for 2020 – 2030, based on source (plant, animal, and yeast), product (protein hydrolysates, infusions, and extracts), application (microbial cell culture, mammalian cell culture, plant tissue culture, and yeast culture), and end user (academic and research institutes, biopharmaceutical companies, and contract research laboratories), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Phenylketonuria Treatment Market To Witness A Growth Of 7%, To Reach Tue, 13 Apr 2021 17:54:25 +0200 http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702294.html http://comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/702294.html persistencemarketresearch persistencemarketresearch

Phenylketonuria (PKU) is an inherited disorder caused by excess of phenylalanine in the blood, which can lead to severe intellectual disabilities. There is no cure for phenylketonuria as yet, and dietary management is the only option to maintain the phenylalanine level in the body. Untreated infants with PKU tend to have unusually light eye, skin, and hair colour due to excess of phenylalanine levels interfering with melanin. Neurological symptoms such as seizures, abnormal muscle movement, tremors, or involuntary movement are some of the symptoms mainly observed in such patients.

Rising prevalence of phenylketonuria among newborns and surging demand for novel formulations to treat the disease have led to increased opportunities for market players. Stakeholders are investing more in research & development for novel treatment solutions within the nutraceutical industry.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/14410

Companies covered in Phenylketonuria Treatment Market Report

  • Arla Foods Ingredients Group P/S
  • Archer Daniels Midland Company
  • BASF SE
  • Chr. Hansen
  • Cargill, Incorporated
  • Seidler Chemical Co, Inc.
  • Nestlé S.A. (Vitaflo International)
  • Reckitt Benckiser Group plc. (Mead Johnson & Company, LLC.)
  • Abbott Laboratories
  • APR Applied Pharma Research S. A.
  • Ajinomoto Co., Inc.
  • VitafriendsPKU
  • Pristine Organics Pvt. Ltd

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/14410

According to the latest report published by Persistence Market Research, the global phenylketonuria treatment market for protein ingredients was valued at US$ 325.9 Mn in 2019, and is predicted to witness an impressive CAGR of over 6% during the forecast period (2020–2030). Similarly, the market for finished products was valued at US$ 565.8 Mn in 2019, and is predicted to witness an impressive CAGR of around 7% through 2030.

Key Takeaways from Phenylketonuria Treatment Market Study       

  • For Protein Ingredients
    • Essential and non-essential amino acid ingredients are expected to contribute more than 1/3 of the revenue share in the market.
    • Powder blend form is expected to gain traction in phenylketonuria treatment, accounting for more than 90% share throughout the forecast years.
    • By targeted customer, consumer healthcare companies hold the highest share of more than 80% in this space.
    • By sales channel, industry sales of protein ingredients are dominating the market.
    • North America holds the highest share in the global phenylketonuria treatment market, owing to the presence of big market players and growing research & development efforts in the region.
    • Key players are focused on expanding their product portfolios and expansion at regional levels through collaborations and acquisitions.
    • The market in the U.S. is projected to be the fastest-growing at a CAGR above 6.5% through 2030. The U.S. holds a big portion of the market revenue and accounts for more than 90% in North America.
  • For Finish Products
    • Essential and non-essential amino acids are expected to contribute more than 1/3 of the revenue share in the market.
    • The powder & granules form is expected to dominate phenylketonuria treatment, accounting for a share of more than 50% through 2030.
    • By targeted customer, adults account for the highest market share of more than 50%.
    • By sales channel, hypermarkets and supermarkets will hold the highest share throughout the forecast period.
    • North America holds more than 40% of the global phenylketonuria treatment market share.
    • Key market players are focusing on expansion of their product portfolios by highly investing in the research & development sector, and are generating high revenue through collaborations and acquisitions.
    • The market in the U.S. is projected to be the fastest-growing, and will expand at a CAGR close to 6% through 2030. The U.S. holds a big portion of the market revenue, and accounts for more than 90% share in North America.

“Increasing prevalence of PKU and rising adoption of PKU diets will upswing the global phenylketonuria treatment market over the coming years,” says an analyst of Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/14410

Collaborations & Acquisitions Key Strategies amongst Market Players

Prominent players in the phenylketonuria treatment market are firming their product ranges through acquisitions and reaching out to emerging markets. Increasing investments and manufacturing capacity expansion are expected to favour growth of the global market over the forecast period.

  • For instance, Mead Johnson Nutrition Company was acquired by the Reckitt Benckiser Group plc (RB). Mead Johnson is now a division of RB, adding its globally-recognized brands, including Phenyl-Free® 1, an iron-fortified PKU infant formula and medical food powder for infants and young children with documented phenylketonuria.
  • Additionally, Abbott Laboratories collaborated with Syngene to inaugurate its first nutrition research & development centre in India.

Various players in the phenylketonuria treatment market are focusing on research & development, product launches, and advanced solutions to strengthen and expand their product portfolios.

  • For instance, Vitaflo USA introduced PKU Sphere™, a powdered, low phenylalanine medical food used in the dietary management of phenylketonuria. The medical food formula is a Glycomacropeptide (GMP)-based medical food containing a balanced mix of GMP and amino acids.
  • Ajinomoto Co., Inc. introduced a new product line, Glytactin BUILD 20/20™ and Glytactin RTD Lite,  new PKU formulas featuring the next generation of Glytactin with 40% less Phe per gram of PE than all other GMP-based PKU medical foods.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the phenylketonuria treatment market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030. The research study is based on PKU ingredients (protein ingredient [Glycomacropeptide (GMP) and essential and non-essential amino acids] and finish products [Glycomacropeptide (GMP) and essential and non-essential amino acids]), targeted customer (protein ingredients [consumer healthcare companies, pharmaceutical companies, and contract manufacturing companies (CMOs)] and finish products [adults, paediatrics, and pregnant women]), form (protein ingredients [powder blend and granules], finish products [powder & granules, tablets, capsules, powder sachets, ready-to-drink, shakes, and other]), and sales channel (protein ingredients [industry sales], finish products [hospital pharmacies, retail pharmacies, online pharmacies, and hypermarkets & supermarkets]), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>